Unit 1 Exam Prep Flashcards
What are the two parts of holoenzymes?
Two parts, protein called apoenzyme and non-protein component called the cofactor (could be loosely bound such as coenzymes or tightly bound such as prosthetic groups)
What is compartmentalization?
Isolate the reaction, substrate or product from other competing reactions
Provide favorable environment for the reaction
Organize enzymes into purposeful pathways
What are Isoenzymes?
Different enzymes that catalyze the same reaction
Usually located in different tissues or organelles
Where is chymotypsin produced? What is it a precursor to? What is the function of its active form?
Produced by pancreas as inactive precursor to chymotrypsinogen
Hydrolyses peptide bond on carbon side of Phe, Tyr, or Trp
What are mechanism-based inhibitors used for? What are some examples?
Mimic or participate in intermediate step of reaction
Penicillin – binds tightly to glycopeptidyl transferases that are required for cell wall synthesis
Allopurinol – “suicide” inhibitor of xanthine oxidase, decrease in urate production, used in the treatment of gout
What are covalent inhibitors?
What are Transition State Analogous?
Form covalent bond with functional groups in catalytic site
Bind more tightly than substrate or product
What are some uses for inhibitors?
Chemotherapy – uses drugs to treat disease
Metabolic control – through allosteric or substrate inhibition and activation
Natural poisons – are secondary metabolites, peptides or proteins
Michaelis-Menten
V(0) = Vmax[S]/(Km+[S])
Km
Affinity of enzyme for a particular substrate
Lineweaver burke plot vs Michaelis Menten
Less points, extrapolation easier,
Reversible inhibitor
Non-covalent bonds, enzyme regains activity through dilution
Irreversible inhibitor
Cannot regain activity through dilution. Covalent interaction between inhibitor and enzyme or very tightly bound EI complex
What are allosteric enzymes? What are the forms that they can take?
Allosteric enzymes are enzymes that change their conformation upon binding an effector. Usually consist of multiple subunits
Subunits can exist in relaxed active (R) or taut inactive (T) conformation
Allosteric effectors promote or inhibit conversion from one conformation to another
Competitive inhibition
Inhibitor binds to the same site as substrate
Inhibition can be reversed by high [S]
Vmax does not change, reachable at high [S]
Km increased, more substrate needed to achieve 1/2Vmax
What is cooperativity binding?
Binding of substrate to one subunit facilitates its binding to the other
First binding is slow – enzyme in T conformation
Triggers the changes in subunits adjacent to high-affinity or relaxed R state
What are some of the advantages of allosteric regulators?
Stronger effect than competitive and noncompetitive inhibitors
May act as activators (don’t occupy active site)
Do not require to resemble S or P
Effect is rapid, as concentration changes in the cell
What are the two most common covalent modifications?
Phosphorylation is the most common modification
AND-ribosylation of Arg or Lys in G-proteins by bacterial toxins
What is protein-protein interaction? Give examples
Can regulate conformation of active sites
PKA – inactive when bound to inhibitory R subunit, activated by cAMP, binding of cAMP to inhibitory subunit changes the conformation of the inhibitor dissociating it from the catalytic site, PKA becomes active
Noncompetitive
Substrate and inhibitor binds at different sites Inhibitor can bind to ES complex Can't be overcome by increased [S] Km does not change Vmax decreased
Regulation by conformational changes
Allosteric activation or inhibition
Phosphorylation or other modifications
Protein-protein interactions
Proteolytic cleavage
What are llosteric activators or inhibitors
Compounds that bind to the allosteric site (not catalytic)
Cause conformational changes that affect affinity for substrate
Allosteric inhibition is the example of noncompetitive inhibition
What are four types of regulation in metabolic pathways?
Rate-limiting step – slowest and irreversible, influences the rest of the pathway
Feedback regulation - product controls its own synthesis
Feed-forward regulation – increase of substrate (disposal of toxic compounds, storage)
Tissue isozymes – same function, different kinetics
What does the lack of chemical signals lead to?
Lack of chemical signals: infertilities (lack of gonadotropin), type I diabetes mellitus (lack of insulin), hypothyroidism (reduced thyroid hormone levels), hormone deficiencies
Calmodulin
Calcium binding proteins, binds to and regulates different protein targets. Has four Ca2+ binding sites. Binding of Ca2+ leads to conformational change.
In the liver, binding of Ca2+ activates GPK, which is an activator of glycogen phosphorylase, a key activator in glycogenolysis